Sex differences in the subjective effects of oral Δ9-THC in cannabis users

Pharmacology Biochemistry and Behavior

Volumn 152, Issue , 2017, Pages 44-51

  Fogel, Jessica S ^b   Kelly, Thomas H ^a,b   Westgate, Philip M ^c   Lile, Joshua A ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

Author keywords

Cannabis; Drug discrimination; Gender; Marijuana; Self report

Indexed keywords

BACLOFEN; CAFFEINE; DIAZEPAM; DRONABINOL; GABAPENTIN; HYDROMORPHONE; METHYLPHENIDATE; NABILONE; PLACEBO; TIAGABINE; TRIAZOLAM;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANNABIS ADDICTION; CANNABIS USE; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DIGIT SYMBOL SUBSTITUTION TEST; DRUG DISCRIMINATION TEST; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; HEART RATE; HUMAN; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; QUESTIONNAIRE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SKIN TEMPERATURE; SMOKING; SYSTOLIC BLOOD PRESSURE; VISUAL ANALOG SCALE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; PERCEPTIVE DISCRIMINATION; SELF EVALUATION; SEXUAL DEVELOPMENT; YOUNG ADULT;

DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRONABINOL; FEMALE; HEART RATE; HUMANS; MALE; PSYCHOMOTOR PERFORMANCE; RETROSPECTIVE STUDIES; SELF-ASSESSMENT; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 84957818752     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2016.01.007     Document Type: Article

References (59)

1. Agrawal, A., Gardner, C.O., Prescott, C.A., Kendler, K.S., The differential impact of risk factors on illicit drug involvement in females. Soc. Psychiatry Psychiatr. Epidemiol. 40:6 (2005), 454–466.
2. American Psychiatric Association, Diagnostic and statistical manual of mental disorders (4th ed., text rev.). 2000, Washington, DC.
3. Babalonis, S., Emurian, C.S., Martin, C.A., Lile, J.A., Kelly, T.H., Modulation of the discriminative stimulus effects of triazolam across the menstrual cycle phase in healthy pre-menopausal women. Drug Alcohol Depend. 94:1 (2008), 276–280.
4. Babalonis, S., Lile, J.A., Martin, C.A., Kelly, T.H., Physiological doses of progesterone potentiate the effects of triazolam in healthy, premenopausal women. Psychopharmacology 215:3 (2011), 429–439.
5. Bernstein, D.P., Childhood trauma and drug addiction: assessment, diagnosis, and treatment. Alcohol. Treat. Q. 18:3 (2000), 19–30.
6. Castelli, M.P., Fadda, P., Casu, A., Spano, M.S., Casti, A., Fratta, W., Fattore, L., Male and female rats differ in brain cannabinoid CB1 receptor density and function and in behavioural traits predisposing to drug addiction: effect of ovarian hormones. Curr. Pharm. Des. 20:13 (2014), 2100–2113.
7. Christensen, J., Væth, M., Wenzel, A., Thermographic imaging of facial skin—gender differences and temperature changes over time in healthy subjects. Dentomaxillofac. Radiol. 41:8 (2012), 662–667.
8. Cooper, Z.D., Haney, M., Comparison of the subjective, physiologic and pharmacokinetic effects of marijuana smoked in cigarette paper (joints) versus cigar paper (blunts). Drug Alcohol Depend. 103:3 (2009), 107–113.
9. Cooper, Z.D., Haney, M., Investigation of sex-dependent effects of cannabis in daily cannabis smokers. Drug Alcohol Depend. 136 (2014), 85–91.
10. Copersino, M.L., Boyd, S.J., Tashkin, D.P., Huestis, M.A., Heishman, S.J., Dermand, J.C., Simmons, M.S., Gorelick, D.A., Sociodemographic characteristics of cannabis smokers and the experience of cannabis withdrawal. Am. J. Drug Alcohol Abuse 36:6 (2010), 311–319.
11. Craft, R.M., Leitl, M.D., Gonadal hormone modulation of the behavioral effects of delta9-tetrahydrocannabinol in male and female rats. Eur. J. Pharmacol. 578:1 (2008), 37–42.
12. Ehlers, C.L., Gizer, I.R., Vieten, C., Gilder, D.A., Stouffer, G.M., Lau, P., Wilhelmsen, K.C., Cannabis dependence in the San Francisco Family Study: age of onset of use, DSM-IV symptoms, withdrawal, and heritability. Addict. Behav. 35:2 (2010), 102–110.
13. Fattore, L., Spano, M.S., Altea, S., Angius, P., Fadda, W., Fratta, W., Cannabinoid self-administration in rats: sex differences and the influence of ovarian function. Br. J. Pharmacol. 152:5 (2007), 795–804.
14. Gonzalez, S., Bisogno, T., Wenger, T., Manzanares, J., Milone, A., Berrendero, F., Di Marzo, V., Ramos, J.A., Fernandez-Ruiz, J.J., Sex steroid influence on cannabinoid CB 1 receptor mRNA and endocannabinoid levels in the anterior pituitary gland. Biochem. Biophys. Res. Commun. 270:1 (2000), 260–266.
15. Griffin, M.L., Mendelson, J.H., Mello, N.K., Lex, B.W., Marihuana use across the menstrual cycle. Drug Alcohol Depend. 18:2 (1986), 213–224.
16. 9-THC in male marijuana smokers in a laboratory choice procedure. Psychopharmacology 181:2 (2005), 237–243.
17. Heishman, S.J., Stitzer, M.L., Yingling, J.E., Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance. Pharmacol. Biochem. Behav. 34:1 (1989), 173–179.
18. Hernandez-Avila, C.A., Rounsaville, B.J., Kranzler, H.R., Opioid-, cannabis-and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend. 74:3 (2004), 265–272.
19. Higuera-Matas, A., Miguéns, M., Coria, S.M., Assis, M.A., Borcel, É., del Olmo, N., Ambrosio, E., Sex-specific disturbances of the glutamate/GABA balance in the hippocampus of adult rats subjected to adolescent cannabinoid exposure. Neuropharmacology 62:5 (2012), 1975–1984.
20. Huestis, M.A., Henningfield, J.E., Cone, E.J., Blood cannabinoids I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J. Anal. Toxicol. 16:5 (1992), 276–282.
21. Justice, A.J., de Wit, H., Acute effects of estradiol pretreatment on the response to d-amphetamine in women. Neuroendocrinology 71:1 (2000), 51–59.
22. Justice, A.J., de Wit, H., Acute effects of d-amphetamine during the early and late follicular phases of the menstrual cycle in women. Pharmacol. Biochem. Behav. 66:3 (2000), 509–515.
23. 9-tetrahydrocannabinol on repeated acquisition and performance of response sequences and on self-reports in humans. Behav. Pharmacol. 5:1 (1994), 71–78.
24. Kamien, J.B., Bickel, W.K., Oliveto, A.H., Higgins, S.T., Hughes, J.R., Richards, A.T., Badger, G.J., Placebo-effects contribute to differences in the acquisition of drug discrimination by humans: a retrospective analysis. Behav. Pharmacol. 6:2 (1995), 187–194.
25. Kelly, T.H., Foltin, R.W., Emurian, C.S., Fischman, M.W., Multidimensional behavioral effects of marijuana. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 14:6 (1990), 885–902.
26. Kelly, T.H., Foltin, R.W., Emurian, C.S., Fischman, M.W., Performance-based testing for drugs of abuse: dose and time profiles of marijuana, amphetamine, alcohol, and diazepam. J. Anal. Toxicol. 17:5 (1993), 264–272.
27. Khan, S.S., Secades-Villa, R., Okuda, M., Wang, S., Pérez-Fuentes, G., Kerridge, B.T., Blanco, C., Gender differences in cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions. Drug Alcohol Depend. 130:1 (2013), 101–108.
28. 9-tetrahydrocannabinol in frequent and infrequent marijuana users. Pharmacol. Biochem. Behav. 63:1 (1999), 137–142.
29. Lex, B.W., Mendelson, J.H., Bavli, S., Harvey, K., Mello, N.K., Effects of acute marijuana smoking on pulse rate and mood states in women. Psychopharmacology 84:2 (1984), 178–187.
30. Lile, J.A., Kelly, T.H., Hays, L.R., The reinforcing, self-reported, performance and physiological effects of Δ9-tetrahydrocannabinol, triazolam, hydromorphone and methylphenidate in cannabis users. Behav. Pharmacol., 21(1), 2010, 29.
31. 9-tetrahydrocannabinol. Clin. Neuropharmacol. 33:5 (2010), 235–242.
32. 9-THC. Drug Alcohol Depend. 116:1 (2011), 86–92.
33. 9-THC. Drug Alcohol Depend. 126:1 (2012), 216–223.
34. 9-THC. Drug Alcohol Depend. 122:1 (2012), 61–69.
35. 9-THC. Drug Alcohol Depend. 143 (2014), 141–148.
36. 9-tetrahydrocannabinol. Psychopharmacology 203:2 (2009), 241–250.
37. Lile, J.A., Kendall, S.L., Babalonis, S., Martin, C.A., Kelly, T.H., Evaluation of estradiol administration on the discriminative-stimulus and subject-rated effects of d-amphetamine in healthy pre-menopausal women. Pharmacol. Biochem. Behav. 87:2 (2007), 258–266.
38. Lile, J.A., Morgan, D., Freedland, C.S., Sinnott, R.S., Davies, H.M., Nader, M.A., Self-administration of two long-acting monoamine transport blockers in rhesus monkeys. Psychopharmacology 152:4 (2000), 414–421.
39. 9-THC. 2015 Unpublished data.
40. Marusich, J.A., Craft, R.M., Lefever, T.W., Wiley, J.L., The impact of gonadal hormones on cannabinoid dependence. Exp. Clin. Psychopharmacol., 23(4), 2015, 206.
41. McLeod, D.R., Griffiths, R.R., Bigelow, G.E., Yingling, J., An automated version of the digit symbol substitution test (DSST). Behav. Res. Methods Instrum. 14:5 (1982), 463–466.
42. Mendelson, J.H., Mello, N.K., Sholar, M.B., Siegel, A.J., Kaufman, M.J., Levin, J.M.,.. Cohen, B.M., Cocaine pharmacokinetics in men and in women during the follicular and luteal phases of the menstrual cycle. Neuropsychopharmacology 21:2 (1999), 294–303.
43. Nader, M.A., Reboussin, D.M., The effects of behavioral history on cocaine self-administration by rhesus monkeys. Psychopharmacology 115:1–2 (1994), 53–58.
44. Reed, B.G., Mowbray, C.T., Mental illness and substance abuse: implications for women's health and health care access. J. Am. Med. Women's Assoc. 54:2 (1999), 71–78.
45. Rodriguez de Fonseca, F.R., Cebeira, M., Ramos, J.A., Martin, M., Fernandez-Ruiz, J.J., Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement. Life Sci. 54:3 (1994), 159–170.
46. Ryan, S.M., Goldberger, A.L., Pincus, S.M., Mietus, J., Lipsitz, L.A., Gender-and age-related differences in heart rate dynamics: are women more complex than men?. J. Am. Coll. Cardiol. 24:7 (2004), 1700–1707.
47. Schepis, T.S., Desai, R.A., Cavallo, D.A., Smith, A.E., McFetridge, A., Liss, T.B., Potenza, M.N., Krishnan-Sarin, S., Gender differences in adolescent marijuana use and associated psychosocial characteristics. J. Addict. Med., 5(1), 2011, 65.
48. Singha, A.K., McCance-Katz, E.F., Heck, S.A., Kosten, T.R., Oliveto, A., Individual differences in humans responding under a cocaine discrimination procedure: discriminators versus nondiscriminators. Exp. Clin. Psychopharmacol., 7(4), 1999, 391.
49. Substance Abuse and Mental Health Services Administration, Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48, HHS Publication No. (SMA) 14–4863. 2014, Substance Abuse and Mental Health Services Administration, Rockville, MD.
50. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality, The TEDS Report: Gender Differences in Primary Substance of Abuse Across Age Groups. Rockville, MD. 2014 April 3, Treatment Episode Data Set – Admissions (TEDS-A), Analysis ran on 2015–01-27 (02:47 PM ESTEST) using SDA 3.5: Tables, 2014.
51. Toland, S.L., Green, W., DRE field testing of drug impaired drivers. Watts, V., (eds.) The Effects of Drugs on Human Performance and Behavior: Drugs and Driving/Drugs in the Workplace, 1991, American Academy of Forensic Sciences, Colorado.
52. Tseng, A.H., Craft, R.M., Sex differences in antinociceptive and motoric effects of cannabinoids. Eur. J. Pharmacol. 430:1 (2001), 41–47.
53. Umetani, K., Singer, D.H., McCraty, R., Atkinson, M., Twenty-four hour time domain heart rate variability and heart rate: relations to age and gender over nine decades. J. Am Coll. Cardiol. 31:3 (1998), 593–601.
54. Vansickel, A.R., Hays, L.R., Rush, C.R., Discriminative-stimulus effects of triazolam in women and men. Am. J. Drug Alcohol Abuse 32:3 (2006), 329–349.
55. Vansickel, A.R., Lile, J.A., Stoops, W.W., Rush, C.R., Similar discriminative-stimulus effects of D-amphetamine in women and men. Pharmacol. Biochem. Behav. 87:2 (2007), 289–296.
56. 9-tetrahydrocannabinol in men and women. Clin. Pharmacol. Ther. 34:3 (1983), 352–363.
57. Westermeyer, J., Boedicker, A.E., Course, severity, and treatment of substance abuse among women versus men. Am. J. Drug Alcohol Abuse 26:4 (2000), 523–535.
58. White, T.L., Justice, A.J., de Wit, H., Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol. Biochem. Behav. 73:4 (2002), 729–741.
59. Wilson, W.H., Ellinwood, E.H., Mathew, R.J., Johnson, K., Effects of marijuana on performance of a computerized cognitive-neuromotor test battery. Psychiatry Res. 51:2 (1994), 115–125.